Ratification Date: 25/07/2025

Next Review Date: 25/07/2027

Docetaxel (Taxotere®) – Non-small cell lung cancer – as per NHS England policy

Drug Name (Brand) Docetaxel  (Taxotere®)
Indication Non-small cell lung cancer – as per NHS England policy
Traffic Light Classification Red
NICE TA (plus link)  
Further Information:

NICE recommendations, summary of meeting discussions, links to additional supporting docs etc.

 

April 2013: NHS England SCG took over commissioning responsibility.

 

November 2013: NICE treatemnet pathway for NSCLC – http://pathways.nice.org.uk/pathways/lung-cancer

 

 

 

 

Date of TAG recommendation / ratification 11/1/2013 Review Date